Cargando...
Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin
Diabetic ketoacidosis is a leading cause of morbidity and mortality in diabetic patients, and its diagnosis should be timely and accurate. SGLT2 inhibitors are a new class of antidiabetic medications that increase the renal excretion of glucose. It is thought that increased urinary excretion of gluc...
Gardado en:
| Publicado en: | Case Rep Crit Care |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7350083/ https://ncbi.nlm.nih.gov/pubmed/32695525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7437892 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|